Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

On January 15, 2020, the Compensation and Management Development Committee of the Board of Directors of Syneos Health, Inc. (the "Company") approved entering into an Executive Service Agreement Amendment (the "Amendment") with Alistair Macdonald, the Chief Executive Officer of the Company. Pursuant to the Amendment, Mr. Macdonald's Executive Service Agreement was amended to provide that, if Mr. Macdonald's employment is terminated without cause or he resigns for good reason, then he will receive a cash severance payment equal to two times (or three times if such termination occurs during the period commencing three months prior to and ending 24 months after a change in control of the Company) the sum of (i) his base salary plus (ii) his annual target bonus for the year of termination. Additionally, Mr. Macdonald will be entitled to 36 months of health care coverage continuation.

The foregoing summary of the Amendment is qualified in its entirety by reference to the full text of the Form of the Amendment, which is filed as Exhibit 10.1 to this Form 8-K, and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits


   Exhibit
     No.                                       Description

  Exhibit 10.1        Form of Amendment No. 2 to Executive Service Agreement between
                    Alistair Macdonald and INC Research Holding Limited, dated
                    January 15, 2020.

  Exhibit 104       Cover Page Interactive Data File - the cover page XBRL tags are
                    embedded within the Inline XBRL document

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses